Published in Anaerobe on February 07, 2008
Use of an EZ-Tn5-based random mutagenesis system to identify a novel toxin regulatory locus in Clostridium perfringens strain 13. PLoS One (2009) 1.34
Isolation of Clostridium perfringens type B in an individual at first clinical presentation of multiple sclerosis provides clues for environmental triggers of the disease. PLoS One (2013) 1.14
Type IV pili and the CcpA protein are needed for maximal biofilm formation by the gram-positive anaerobic pathogen Clostridium perfringens. Infect Immun (2008) 1.14
Toxin plasmids of Clostridium perfringens. Microbiol Mol Biol Rev (2013) 1.07
Freshwater suspended sediments and sewage are reservoirs for enterotoxin-positive Clostridium perfringens. Appl Environ Microbiol (2010) 0.90
Detection of enterotoxigenic Clostridium perfringens in meat samples by using molecular methods. Appl Environ Microbiol (2011) 0.86
Lytic enzyme discovery through multigenomic sequence analysis in Clostridium perfringens. Appl Microbiol Biotechnol (2010) 0.86
Recombinant expression of two bacteriophage proteins that lyse clostridium perfringens and share identical sequences in the C-terminal cell wall binding domain of the molecules but are dissimilar in their N-terminal active domains. J Agric Food Chem (2010) 0.86
Contributions of NanI sialidase to Caco-2 cell adherence by Clostridium perfringens type A and C strains causing human intestinal disease. Infect Immun (2014) 0.85
Sensitive quantification of Clostridium perfringens in human feces by quantitative real-time PCR targeting alpha-toxin and enterotoxin genes. BMC Microbiol (2015) 0.83
Enterotoxigenic Clostridium perfringens: detection and identification. Microbes Environ (2012) 0.83
Structure-function analysis of peptide signaling in the Clostridium perfringens Agr-like quorum sensing system. J Bacteriol (2015) 0.80
Effect of Lactobacillus fermentum on beta2 toxin production by Clostridium perfringens. Appl Environ Microbiol (2011) 0.80
Comparative genomic hybridization analysis shows different epidemiology of chromosomal and plasmid-borne cpe-carrying Clostridium perfringens type A. PLoS One (2012) 0.80
A Five Site Clostridium Perfringens Food-Borne Outbreak: A Retrospective Cohort Study. Zdr Varst (2014) 0.75
Clostridium Perfringens Epsilon Toxin Binds to Membrane Lipids and Its Cytotoxic Action Depends on Sulfatide. PLoS One (2015) 0.75
Genomic diversity of Clostridium perfringens strains isolated from food and human sources. Iran J Vet Res (2016) 0.75
Does the Gut Microbiota Influence Immunity and Inflammation in Multiple Sclerosis Pathophysiology? J Immunol Res (2017) 0.75
The Generation and Characterization of Recombinant Protein and Antibodies of Clostridium perfringens Beta2 Toxin. J Immunol Res (2016) 0.75
Oral Multiple Sclerosis Drugs Inhibit the In vitro Growth of Epsilon Toxin Producing Gut Bacterium, Clostridium perfringens. Front Cell Infect Microbiol (2017) 0.75
Human Food Poisoning Due to Growth of Clostridium perfringens (C. welchii) in Freshly Cooked Chicken: Preliminary Note. J Bacteriol (1945) 8.34
Sporulation and enterotoxin production by mutants of Clostridium perfringens. J Bacteriol (1972) 3.25
Inactivation of the gene (cpe) encoding Clostridium perfringens enterotoxin eliminates the ability of two cpe-positive C. perfringens type A human gastrointestinal disease isolates to affect rabbit ileal loops. Mol Microbiol (1999) 2.99
Comparison of Western immunoblots and gene detection assays for identification of potentially enterotoxigenic isolates of Clostridium perfringens. J Clin Microbiol (1994) 2.81
The enterotoxin gene (cpe) of Clostridium perfringens can be chromosomal or plasmid-borne. Mol Microbiol (1995) 2.71
Evidence that the enterotoxin gene can be episomal in Clostridium perfringens isolates associated with non-food-borne human gastrointestinal diseases. J Clin Microbiol (1998) 2.60
Occurrence of Clostridium perfringens beta2-toxin amongst animals, determined using genotyping and subtyping PCR assays. Epidemiol Infect (2000) 2.18
Association of beta2 toxin production with Clostridium perfringens type A human gastrointestinal disease isolates carrying a plasmid enterotoxin gene. Mol Microbiol (2005) 2.06
Genotyping of enterotoxigenic Clostridium perfringens fecal isolates associated with antibiotic-associated diarrhea and food poisoning in North America. J Clin Microbiol (2001) 2.00
Comparison of fecal microflora of elderly persons in rural and urban areas of Japan. Appl Environ Microbiol (1989) 1.95
Enterotoxigenic Clostridium perfringens: a possible cause of antibiotic-associated diarrhoea. Lancet (1984) 1.89
Enterotoxin plasmid from Clostridium perfringens is conjugative. Infect Immun (2001) 1.76
Detection of enterotoxigenic Clostridium perfringens type A isolates in American retail foods. Appl Environ Microbiol (2004) 1.66
Organization of the plasmid cpe Locus in Clostridium perfringens type A isolates. Infect Immun (2002) 1.63
Complete sequencing and diversity analysis of the enterotoxin-encoding plasmids in Clostridium perfringens type A non-food-borne human gastrointestinal disease isolates. J Bacteriol (2006) 1.63
Epidemiology of diarrhoea caused by enterotoxigenic Clostridium perfringens. J Med Microbiol (1985) 1.56
Persistent high numbers of Clostridium perfringens in the intestines of Japanese aged adults. Jpn J Microbiol (1976) 1.56
Detection of Clostridium perfringens and its enterotoxin in cases of sporadic diarrhoea. J Clin Pathol (1992) 1.51
Production and characterization of monoclonal antibodies against Clostridium perfringens type A enterotoxin. Infect Immun (1985) 1.48
The effects of Clostridium perfringens enterotoxin on morphology, viability, and macromolecular synthesis in Vero cells. J Cell Physiol (1979) 1.44
Multiplex PCR genotyping assay that distinguishes between isolates of Clostridium perfringens type A carrying a chromosomal enterotoxin gene (cpe) locus, a plasmid cpe locus with an IS1470-like sequence, or a plasmid cpe locus with an IS1151 sequence. J Clin Microbiol (2004) 1.40
Evaluation of ELISA, RPLA, and Vero cell assays for detecting Clostridium perfringens enterotoxin in faecal specimens. J Clin Pathol (1988) 1.32
Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus. J Clin Microbiol (2006) 1.31
Faecal carriage of Clostridium perfringens. J Hyg (Lond) (1985) 1.30
Association of iota-like toxin and Clostridium spiroforme with both spontaneous and antibiotic-associated diarrhea and colitis in rabbits. J Clin Microbiol (1983) 1.27
Humans as reservoir for enterotoxin gene--carrying Clostridium perfringens type A. Emerg Infect Dis (2006) 1.19
Laboratory diagnosis of Clostridium perfringens antibiotic-associated diarrhoea. J Med Microbiol (2002) 1.15
The nature of a neutralising substance for Clostridium welchii alpha-toxin in faeces. J Pathol Bacteriol (1959) 1.15
Activation and injury of Clostridium perfringens spores by alcohols. Appl Environ Microbiol (1985) 1.12
Enterotoxigenic Clostridium perfringens as a cause of sporadic cases of diarrhoea. J Med Microbiol (1995) 1.10
Infectious diarrhea due to Clostridium perfringens. J Infect Dis (1988) 1.09
Genotyping of Clostridium perfringens isolates collected from food poisoning outbreaks and healthy individuals in Japan based on the cpe locus. Jpn J Infect Dis (2007) 1.06
Similar frequency of detection of Clostridium perfringens enterotoxin and Clostridium difficile toxins in patients with antibiotic-associated diarrhea. Eur J Clin Microbiol Infect Dis (2001) 1.01
Evidence for antibiotic induced Clostridium perfringens diarrhoea. J Clin Pathol (2001) 1.01
An investigation into Clostridium perfringens enterotoxin-associated diarrhoea. J Hosp Infect (1991) 0.94
Recurrent diarrhoea in a dog associated with Clostridium perfringens type A. Vet Rec (1983) 0.93
Detection and quantification of four species of the genus Clostridium in infant feces. Microbiol Immunol (2005) 0.88
Treatment of Clostridium perfringens enterotoxin-associated diarrhoea with metronidazole. J Infect (1985) 0.85
Proteolysis of Clostridium perfringens type A enterotoxin during purification. Infect Immun (1990) 0.82
Effect of protease on the production of Clostridium perfringens alpha toxin. Jpn J Med Sci Biol (1977) 0.80
Enumeration of Clostridium perfringens spores in human feces: comparison of four culture media. J Assoc Off Anal Chem (1988) 0.77
Enterotoxigenic Clostridium perfringens type A in selected humans. II. A cohort study. Rev Latinoam Microbiol (1976) 0.77
Skewed genomic variability in strains of the toxigenic bacterial pathogen, Clostridium perfringens. Genome Res (2006) 2.84
Association of beta2 toxin production with Clostridium perfringens type A human gastrointestinal disease isolates carrying a plasmid enterotoxin gene. Mol Microbiol (2005) 2.06
Construction of an alpha toxin gene knockout mutant of Clostridium perfringens type A by use of a mobile group II intron. Appl Environ Microbiol (2005) 2.01
Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters. J Infect Dis (2006) 1.99
Beta toxin is essential for the intestinal virulence of Clostridium perfringens type C disease isolate CN3685 in a rabbit ileal loop model. Mol Microbiol (2008) 1.78
Detection of enterotoxigenic Clostridium perfringens type A isolates in American retail foods. Appl Environ Microbiol (2004) 1.66
Organization of the plasmid cpe Locus in Clostridium perfringens type A isolates. Infect Immun (2002) 1.63
Complete sequencing and diversity analysis of the enterotoxin-encoding plasmids in Clostridium perfringens type A non-food-borne human gastrointestinal disease isolates. J Bacteriol (2006) 1.63
The mouse model of amebic colitis reveals mouse strain susceptibility to infection and exacerbation of disease by CD4+ T cells. J Immunol (2002) 1.63
Epsilon-toxin is required for most Clostridium perfringens type D vegetative culture supernatants to cause lethality in the mouse intravenous injection model. Infect Immun (2005) 1.49
Dissecting the contributions of Clostridium perfringens type C toxins to lethality in the mouse intravenous injection model. Infect Immun (2006) 1.49
Multiplex PCR genotyping assay that distinguishes between isolates of Clostridium perfringens type A carrying a chromosomal enterotoxin gene (cpe) locus, a plasmid cpe locus with an IS1470-like sequence, or a plasmid cpe locus with an IS1151 sequence. J Clin Microbiol (2004) 1.40
Identification, distribution, and expression of novel genes in 10 clinical isolates of nontypeable Haemophilus influenzae. Infect Immun (2005) 1.39
Contact with enterocyte-like Caco-2 cells induces rapid upregulation of toxin production by Clostridium perfringens type C isolates. Cell Microbiol (2009) 1.38
Further comparison of temperature effects on growth and survival of Clostridium perfringens type A isolates carrying a chromosomal or plasmid-borne enterotoxin gene. Appl Environ Microbiol (2006) 1.38
Use of an EZ-Tn5-based random mutagenesis system to identify a novel toxin regulatory locus in Clostridium perfringens strain 13. PLoS One (2009) 1.34
Genotyping and phenotyping of beta2-toxigenic Clostridium perfringens fecal isolates associated with gastrointestinal diseases in piglets. J Clin Microbiol (2003) 1.32
Structure of the claudin-binding domain of Clostridium perfringens enterotoxin. J Biol Chem (2007) 1.32
Effects of Clostridium perfringens beta-toxin on the rabbit small intestine and colon. Infect Immun (2008) 1.32
Development of a duplex PCR genotyping assay for distinguishing Clostridium perfringens type A isolates carrying chromosomal enterotoxin (cpe) genes from those carrying plasmid-borne enterotoxin (cpe) genes. J Clin Microbiol (2003) 1.31
Virulence plasmid diversity in Clostridium perfringens type D isolates. Infect Immun (2007) 1.30
Revised nomenclature of Clostridium difficile toxins and associated genes. J Med Microbiol (2005) 1.28
A novel small acid soluble protein variant is important for spore resistance of most Clostridium perfringens food poisoning isolates. PLoS Pathog (2008) 1.27
Comparison of virulence plasmids among Clostridium perfringens type E isolates. Infect Immun (2007) 1.24
Identification of a prepore large-complex stage in the mechanism of action of Clostridium perfringens enterotoxin. Infect Immun (2007) 1.23
The Agr-like quorum-sensing system regulates sporulation and production of enterotoxin and beta2 toxin by Clostridium perfringens type A non-food-borne human gastrointestinal disease strain F5603. Infect Immun (2011) 1.23
Extensive genomic plasticity in Pseudomonas aeruginosa revealed by identification and distribution studies of novel genes among clinical isolates. Infect Immun (2006) 1.20
Comparative effects of osmotic, sodium nitrite-induced, and pH-induced stress on growth and survival of Clostridium perfringens type A isolates carrying chromosomal or plasmid-borne enterotoxin genes. Appl Environ Microbiol (2006) 1.18
Compositional and stoichiometric analysis of Clostridium perfringens enterotoxin complexes in Caco-2 cells and claudin 4 fibroblast transfectants. Cell Microbiol (2007) 1.17
Epsilon-toxin plasmids of Clostridium perfringens type D are conjugative. J Bacteriol (2007) 1.16
Genetic characterization of type A enterotoxigenic Clostridium perfringens strains. PLoS One (2009) 1.16
Both epsilon-toxin and beta-toxin are important for the lethal properties of Clostridium perfringens type B isolates in the mouse intravenous injection model. Infect Immun (2007) 1.15
Prevalence of enterotoxigenic Clostridium perfringens Isolates in Pittsburgh (Pennsylvania) area soils and home kitchens. Appl Environ Microbiol (2007) 1.15
Death pathways activated in CaCo-2 cells by Clostridium perfringens enterotoxin. Infect Immun (2003) 1.14
Characterization of virulence plasmid diversity among Clostridium perfringens type B isolates. Infect Immun (2009) 1.14
Clostridium difficile binary toxin (CDT) and diarrhea. Anaerobe (2011) 1.12
Sequencing and diversity analyses reveal extensive similarities between some epsilon-toxin-encoding plasmids and the pCPF5603 Clostridium perfringens enterotoxin plasmid. J Bacteriol (2008) 1.11
The importance of calcium influx, calpain and calmodulin for the activation of CaCo-2 cell death pathways by Clostridium perfringens enterotoxin. Cell Microbiol (2005) 1.11
Evaluating the involvement of alternative sigma factors SigF and SigG in Clostridium perfringens sporulation and enterotoxin synthesis. Infect Immun (2010) 1.10
Development and application of new mouse models to study the pathogenesis of Clostridium perfringens type C Enterotoxemias. Infect Immun (2009) 1.10
Structure-guided design of a high-affinity platelet integrin αIIbβ3 receptor antagonist that disrupts Mg²⁺ binding to the MIDAS. Sci Transl Med (2012) 1.07
Toxin plasmids of Clostridium perfringens. Microbiol Mol Biol Rev (2013) 1.07
Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease. Future Microbiol (2014) 1.07
Characterization of toxin plasmids in Clostridium perfringens type C isolates. Infect Immun (2010) 1.05
Sialidases affect the host cell adherence and epsilon toxin-induced cytotoxicity of Clostridium perfringens type D strain CN3718. PLoS Pathog (2011) 1.03
Structure of the food-poisoning Clostridium perfringens enterotoxin reveals similarity to the aerolysin-like pore-forming toxins. J Mol Biol (2011) 1.02
Evidence that the Agr-like quorum sensing system regulates the toxin production, cytotoxicity and pathogenicity of Clostridium perfringens type C isolate CN3685. Mol Microbiol (2011) 1.01
Fine mapping of the N-terminal cytotoxicity region of Clostridium perfringens enterotoxin by site-directed mutagenesis. Infect Immun (2004) 1.01
Evidence for a prepore stage in the action of Clostridium perfringens epsilon toxin. PLoS One (2011) 1.01
A novel cost-effective technology to convert sucrose and homocelluloses in sweet sorghum stalks into ethanol. Biotechnol Biofuels (2013) 1.01
Heme oxygenase-1 prevents cardiac dysfunction in streptozotocin-diabetic mice by reducing inflammation, oxidative stress, apoptosis and enhancing autophagy. PLoS One (2013) 1.00
Noncytotoxic Clostridium perfringens enterotoxin (CPE) variants localize CPE intestinal binding and demonstrate a relationship between CPE-induced cytotoxicity and enterotoxicity. Infect Immun (2008) 0.99
Identification of a claudin-4 residue important for mediating the host cell binding and action of Clostridium perfringens enterotoxin. Infect Immun (2009) 0.98
Necrotic enteritis-derived Clostridium perfringens strain with three closely related independently conjugative toxin and antibiotic resistance plasmids. MBio (2011) 0.98
Predominant characteristics of CTX-M-producing Klebsiella pneumoniae isolates from patients with lower respiratory tract infection in multiple medical centers in China. FEMS Microbiol Lett (2012) 0.97
Identification of novel Clostridium perfringens type E strains that carry an iota toxin plasmid with a functional enterotoxin gene. PLoS One (2011) 0.97
Structural and therapeutic insights from the species specificity and in vivo antithrombotic activity of a novel alphaIIb-specific alphaIIbbeta3 antagonist. Blood (2009) 0.96
CodY is a global regulator of virulence-associated properties for Clostridium perfringens type D strain CN3718. MBio (2013) 0.95
Development and application of an oral challenge mouse model for studying Clostridium perfringens type D infection. Infect Immun (2007) 0.94
Further characterization of Clostridium perfringens small acid soluble protein-4 (Ssp4) properties and expression. PLoS One (2009) 0.93
Effects of limiting extension at the alphaIIb genu on ligand binding to integrin alphaIIbbeta3. J Biol Chem (2010) 0.93
Development and characterization of a pooled Haemophilus influenzae genomic library for the evaluation of gene expression changes associated with mucosal biofilm formation in otitis media. Int J Pediatr Otorhinolaryngol (2003) 0.92
Role of the Agr-like quorum-sensing system in regulating toxin production by Clostridium perfringens type B strains CN1793 and CN1795. Infect Immun (2012) 0.92
Human claudin-8 and -14 are receptors capable of conveying the cytotoxic effects of Clostridium perfringens enterotoxin. MBio (2013) 0.92
Use of Clostridium perfringens Enterotoxin and the Enterotoxin Receptor-Binding Domain (C-CPE) for Cancer Treatment: Opportunities and Challenges. J Toxicol (2011) 0.92
Mapping early conformational changes in alphaIIb and beta3 during biogenesis reveals a potential mechanism for alphaIIbbeta3 adopting its bent conformation. Blood (2007) 0.92
Genotypic and phenotypic characterization of Clostridium perfringens isolates from Darmbrand cases in post-World War II Germany. Infect Immun (2012) 0.91
Development and application of a mouse intestinal loop model to study the in vivo action of Clostridium perfringens enterotoxin. Infect Immun (2011) 0.91
Clostridium perfringens epsilon toxin increases the small intestinal permeability in mice and rats. PLoS One (2009) 0.90
High expression of transgene protein in Spirodela. Plant Cell Rep (2007) 0.90
Functional and computational studies of the ligand-associated metal binding site of beta3 integrins. Proteins (2008) 0.90
DNA sequence analysis of the triose phosphate isomerase gene from isolates of Giardia lamblia. Chin Med J (Engl) (2002) 0.90
Organization of the cpe locus in CPE-positive clostridium perfringens type C and D isolates. PLoS One (2010) 0.89
Detection of enterotoxigenic Clostridium perfringens in meat samples by using molecular methods. Appl Environ Microbiol (2011) 0.86
Cysteine-scanning mutagenesis supports the importance of Clostridium perfringens enterotoxin amino acids 80 to 106 for membrane insertion and pore formation. Infect Immun (2012) 0.86
CD44 Promotes intoxication by the clostridial iota-family toxins. PLoS One (2012) 0.85